img

Global Erythropoietin Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Erythropoietin Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with the peritubular capillary and proximal convoluted tubule.
Erythropoietin Drugs report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Erythropoietin Drugs market is projected to reach US$ 12990 million in 2034, increasing from US$ 9157.8 million in 2022, with the CAGR of 5.2% during the period of 2024 to 2034. Demand from Anemia and Kidney Disorders are the major drivers for the industry.
The retail pharmacies segment dominated the erythropoietin drugs market and accounted for a major part of the overall market share. The ability of retail pharmacies to provide a large customer base for biosimilars coupled with the requirement from anemic patients for EPO drugs as a maintenance therapy is the key contributor to the dominance of this segment in the global market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Erythropoietin Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Amgen
Johnson & Johnson
Roche
Galenica
Emcure
Kyowa Hakko Kirin
3SBio
Biocon
LG Life Sciences
Segment by Type
Epoetin-alfa
Darbepoetin-alfa
Epoetin-beta
Others

Segment by Application


Anemia
Kidney Disorders
Other

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Erythropoietin Drugs market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Erythropoietin Drugs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Erythropoietin Drugs industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Erythropoietin Drugs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Erythropoietin Drugs introduction, etc. Erythropoietin Drugs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Erythropoietin Drugs market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Erythropoietin Drugs Market Overview
1.1 Erythropoietin Drugs Product Overview
1.2 Erythropoietin Drugs Market Segment by Type
1.2.1 Epoetin-alfa
1.2.2 Darbepoetin-alfa
1.2.3 Epoetin-beta
1.2.4 Others
1.3 Global Erythropoietin Drugs Market Size by Type
1.3.1 Global Erythropoietin Drugs Market Size Overview by Type (2018-2034)
1.3.2 Global Erythropoietin Drugs Historic Market Size Review by Type (2018-2024)
1.3.3 Global Erythropoietin Drugs Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Erythropoietin Drugs Sales Breakdown by Type (2018-2024)
1.4.2 Europe Erythropoietin Drugs Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Erythropoietin Drugs Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Erythropoietin Drugs Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Erythropoietin Drugs Sales Breakdown by Type (2018-2024)
2 Global Erythropoietin Drugs Market Competition by Company
2.1 Global Top Players by Erythropoietin Drugs Sales (2018-2024)
2.2 Global Top Players by Erythropoietin Drugs Revenue (2018-2024)
2.3 Global Top Players by Erythropoietin Drugs Price (2018-2024)
2.4 Global Top Manufacturers Erythropoietin Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Erythropoietin Drugs Market Competitive Situation and Trends
2.5.1 Erythropoietin Drugs Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Erythropoietin Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Erythropoietin Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Erythropoietin Drugs Market
2.8 Key Manufacturers Erythropoietin Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Erythropoietin Drugs Status and Outlook by Region
3.1 Global Erythropoietin Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Erythropoietin Drugs Historic Market Size by Region
3.2.1 Global Erythropoietin Drugs Sales in Volume by Region (2018-2024)
3.2.2 Global Erythropoietin Drugs Sales in Value by Region (2018-2024)
3.2.3 Global Erythropoietin Drugs Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Erythropoietin Drugs Forecasted Market Size by Region
3.3.1 Global Erythropoietin Drugs Sales in Volume by Region (2024-2034)
3.3.2 Global Erythropoietin Drugs Sales in Value by Region (2024-2034)
3.3.3 Global Erythropoietin Drugs Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Erythropoietin Drugs by Application
4.1 Erythropoietin Drugs Market Segment by Application
4.1.1 Anemia
4.1.2 Kidney Disorders
4.1.3 Other
4.2 Global Erythropoietin Drugs Market Size by Application
4.2.1 Global Erythropoietin Drugs Market Size Overview by Application (2018-2034)
4.2.2 Global Erythropoietin Drugs Historic Market Size Review by Application (2018-2024)
4.2.3 Global Erythropoietin Drugs Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Erythropoietin Drugs Sales Breakdown by Application (2018-2024)
4.3.2 Europe Erythropoietin Drugs Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Erythropoietin Drugs Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Erythropoietin Drugs Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Erythropoietin Drugs Sales Breakdown by Application (2018-2024)
5 North America Erythropoietin Drugs by Country
5.1 North America Erythropoietin Drugs Historic Market Size by Country
5.1.1 North America Erythropoietin Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Erythropoietin Drugs Sales in Volume by Country (2018-2024)
5.1.3 North America Erythropoietin Drugs Sales in Value by Country (2018-2024)
5.2 North America Erythropoietin Drugs Forecasted Market Size by Country
5.2.1 North America Erythropoietin Drugs Sales in Volume by Country (2024-2034)
5.2.2 North America Erythropoietin Drugs Sales in Value by Country (2024-2034)
6 Europe Erythropoietin Drugs by Country
6.1 Europe Erythropoietin Drugs Historic Market Size by Country
6.1.1 Europe Erythropoietin Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Erythropoietin Drugs Sales in Volume by Country (2018-2024)
6.1.3 Europe Erythropoietin Drugs Sales in Value by Country (2018-2024)
6.2 Europe Erythropoietin Drugs Forecasted Market Size by Country
6.2.1 Europe Erythropoietin Drugs Sales in Volume by Country (2024-2034)
6.2.2 Europe Erythropoietin Drugs Sales in Value by Country (2024-2034)
7 Asia-Pacific Erythropoietin Drugs by Region
7.1 Asia-Pacific Erythropoietin Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Erythropoietin Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Erythropoietin Drugs Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Erythropoietin Drugs Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Erythropoietin Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Erythropoietin Drugs Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Erythropoietin Drugs Sales in Value by Region (2024-2034)
8 Latin America Erythropoietin Drugs by Country
8.1 Latin America Erythropoietin Drugs Historic Market Size by Country
8.1.1 Latin America Erythropoietin Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Erythropoietin Drugs Sales in Volume by Country (2018-2024)
8.1.3 Latin America Erythropoietin Drugs Sales in Value by Country (2018-2024)
8.2 Latin America Erythropoietin Drugs Forecasted Market Size by Country
8.2.1 Latin America Erythropoietin Drugs Sales in Volume by Country (2024-2034)
8.2.2 Latin America Erythropoietin Drugs Sales in Value by Country (2024-2034)
9 Middle East and Africa Erythropoietin Drugs by Country
9.1 Middle East and Africa Erythropoietin Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Erythropoietin Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Erythropoietin Drugs Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Erythropoietin Drugs Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Erythropoietin Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Erythropoietin Drugs Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Erythropoietin Drugs Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Amgen
10.1.1 Amgen Company Information
10.1.2 Amgen Introduction and Business Overview
10.1.3 Amgen Erythropoietin Drugs Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Amgen Erythropoietin Drugs Products Offered
10.1.5 Amgen Recent Development
10.2 Johnson & Johnson
10.2.1 Johnson & Johnson Company Information
10.2.2 Johnson & Johnson Introduction and Business Overview
10.2.3 Johnson & Johnson Erythropoietin Drugs Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Johnson & Johnson Erythropoietin Drugs Products Offered
10.2.5 Johnson & Johnson Recent Development
10.3 Roche
10.3.1 Roche Company Information
10.3.2 Roche Introduction and Business Overview
10.3.3 Roche Erythropoietin Drugs Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Roche Erythropoietin Drugs Products Offered
10.3.5 Roche Recent Development
10.4 Galenica
10.4.1 Galenica Company Information
10.4.2 Galenica Introduction and Business Overview
10.4.3 Galenica Erythropoietin Drugs Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Galenica Erythropoietin Drugs Products Offered
10.4.5 Galenica Recent Development
10.5 Emcure
10.5.1 Emcure Company Information
10.5.2 Emcure Introduction and Business Overview
10.5.3 Emcure Erythropoietin Drugs Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Emcure Erythropoietin Drugs Products Offered
10.5.5 Emcure Recent Development
10.6 Kyowa Hakko Kirin
10.6.1 Kyowa Hakko Kirin Company Information
10.6.2 Kyowa Hakko Kirin Introduction and Business Overview
10.6.3 Kyowa Hakko Kirin Erythropoietin Drugs Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Kyowa Hakko Kirin Erythropoietin Drugs Products Offered
10.6.5 Kyowa Hakko Kirin Recent Development
10.7 3SBio
10.7.1 3SBio Company Information
10.7.2 3SBio Introduction and Business Overview
10.7.3 3SBio Erythropoietin Drugs Sales, Revenue and Gross Margin (2018-2024)
10.7.4 3SBio Erythropoietin Drugs Products Offered
10.7.5 3SBio Recent Development
10.8 Biocon
10.8.1 Biocon Company Information
10.8.2 Biocon Introduction and Business Overview
10.8.3 Biocon Erythropoietin Drugs Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Biocon Erythropoietin Drugs Products Offered
10.8.5 Biocon Recent Development
10.9 LG Life Sciences
10.9.1 LG Life Sciences Company Information
10.9.2 LG Life Sciences Introduction and Business Overview
10.9.3 LG Life Sciences Erythropoietin Drugs Sales, Revenue and Gross Margin (2018-2024)
10.9.4 LG Life Sciences Erythropoietin Drugs Products Offered
10.9.5 LG Life Sciences Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Erythropoietin Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Erythropoietin Drugs Industrial Chain Analysis
11.4 Erythropoietin Drugs Market Dynamics
11.4.1 Erythropoietin Drugs Industry Trends
11.4.2 Erythropoietin Drugs Market Drivers
11.4.3 Erythropoietin Drugs Market Challenges
11.4.4 Erythropoietin Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Erythropoietin Drugs Distributors
12.3 Erythropoietin Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Epoetin-alfa
Table 2. Major Company of Darbepoetin-alfa
Table 3. Major Company of Epoetin-beta
Table 4. Major Company of Others
Table 5. Global Erythropoietin Drugs Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Erythropoietin Drugs Sales by Type (2018-2024) & (K Pcs)
Table 7. Global Erythropoietin Drugs Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Erythropoietin Drugs Sales by Type (2018-2024) & (US& Million)
Table 9. Global Erythropoietin Drugs Market Share in Value by Type (2018-2024)
Table 10. Global Erythropoietin Drugs Price by Type (2018-2024) & (USD/Pcs)
Table 11. Global Erythropoietin Drugs Sales by Type (2024-2034) & (K Pcs)
Table 12. Global Erythropoietin Drugs Sales Market Share in Volume by Type (2024-2034)
Table 13. Global Erythropoietin Drugs Sales by Type (2024-2034) & (US$ Million)
Table 14. Global Erythropoietin Drugs Sales Market Share in Value by Type (2024-2034)
Table 15. Global Erythropoietin Drugs Price by Type (2024-2034) & (USD/Pcs)
Table 16. North America Erythropoietin Drugs Sales by Type (2018-2024) & (K Pcs)
Table 17. North America Erythropoietin Drugs Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Erythropoietin Drugs Sales (K Pcs) by Type (2018-2024)
Table 19. Europe Erythropoietin Drugs Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Erythropoietin Drugs Sales (K Pcs) by Type (2018-2024)
Table 21. Asia-Pacific Erythropoietin Drugs Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Erythropoietin Drugs Sales (K Pcs) by Type (2018-2024)
Table 23. Latin America Erythropoietin Drugs Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Erythropoietin Drugs Sales (K Pcs) by Type (2018-2024)
Table 25. Middle East and Africa Erythropoietin Drugs Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Erythropoietin Drugs Sales by Company (2018-2024) & (K Pcs)
Table 27. Global Erythropoietin Drugs Sales Share by Company (2018-2024)
Table 28. Global Erythropoietin Drugs Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Erythropoietin Drugs Revenue Share by Company (2018-2024)
Table 30. Global Market Erythropoietin Drugs Price by Company (2018-2024) & (USD/Pcs)
Table 31. Global Erythropoietin Drugs Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Erythropoietin Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Erythropoietin Drugs as of 2022)
Table 34. Date of Key Manufacturers Enter into Erythropoietin Drugs Market
Table 35. Key Manufacturers Erythropoietin Drugs Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Erythropoietin Drugs Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 38. Global Erythropoietin Drugs Sales by Region (2018-2024) & (K Pcs)
Table 39. Global Erythropoietin Drugs Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Erythropoietin Drugs Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Erythropoietin Drugs Sales Market Share in Value by Region (2018-2024)
Table 42. Global Erythropoietin Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 43. Global Erythropoietin Drugs Sales by Region (2024-2034) & (K Pcs)
Table 44. Global Erythropoietin Drugs Sales Market Share in Volume by Region (2024-2034)
Table 45. Global Erythropoietin Drugs Sales by Region (2024-2034) & (US$ Million)
Table 46. Global Erythropoietin Drugs Sales Market Share in Value by Region (2024-2034)
Table 47. Global Erythropoietin Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 48. Global Erythropoietin Drugs Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 49. Global Erythropoietin Drugs Sales by Application (2018-2024) & (K Pcs)
Table 50. Global Erythropoietin Drugs Sales Market Share in Volume by Application (2018-2024)
Table 51. Global Erythropoietin Drugs Sales by Application (2018-2024) & (US$ Million)
Table 52. Global Erythropoietin Drugs Sales Market Share in Value by Application (2018-2024)
Table 53. Global Erythropoietin Drugs Price by Application (2018-2024) & (USD/Pcs)
Table 54. Global Erythropoietin Drugs Sales by Application (2024-2034) & (K Pcs)
Table 55. Global Erythropoietin Drugs Sales Market Share in Volume by Application (2024-2034)
Table 56. Global Erythropoietin Drugs Sales by Application (2024-2034) & (US$ Million)
Table 57. Global Erythropoietin Drugs Sales Market Share in Value by Application (2024-2034)
Table 58. Global Erythropoietin Drugs Price by Application (2024-2034) & (USD/Pcs)
Table 59. North America Erythropoietin Drugs Sales by Application (2018-2024) (K Pcs)
Table 60. North America Erythropoietin Drugs Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe Erythropoietin Drugs Sales by Application (2018-2024) (K Pcs)
Table 62. Europe Erythropoietin Drugs Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Erythropoietin Drugs Sales by Application (2018-2024) (K Pcs)
Table 64. Asia-Pacific Erythropoietin Drugs Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America Erythropoietin Drugs Sales by Application (2018-2024) (K Pcs)
Table 66. Latin America Erythropoietin Drugs Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Erythropoietin Drugs Sales by Application (2018-2024) (K Pcs)
Table 68. Middle East and Africa Erythropoietin Drugs Sales by Application (2018-2024) & (US$ Million)
Table 69. North America Erythropoietin Drugs Sales by Country (2018-2024) & (K Pcs)
Table 70. North America Erythropoietin Drugs Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Erythropoietin Drugs Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Erythropoietin Drugs Sales Market Share in Value by Country (2018-2024)
Table 73. North America Erythropoietin Drugs Sales by Country (2024-2034) & (K Pcs)
Table 74. North America Erythropoietin Drugs Sales Market Share in Volume by Country (2024-2034)
Table 75. North America Erythropoietin Drugs Sales by Country (2024-2034) & (US$ Million)
Table 76. North America Erythropoietin Drugs Sales Market Share in Value by Country (2024-2034)
Table 77. Europe Erythropoietin Drugs Sales by Country (2018-2024) & (K Pcs)
Table 78. Europe Erythropoietin Drugs Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Erythropoietin Drugs Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Erythropoietin Drugs Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Erythropoietin Drugs Sales by Country (2024-2034) & (K Pcs)
Table 82. Europe Erythropoietin Drugs Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe Erythropoietin Drugs Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe Erythropoietin Drugs Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific Erythropoietin Drugs Sales by Region (2018-2024) & (K Pcs)
Table 86. Asia-Pacific Erythropoietin Drugs Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Erythropoietin Drugs Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Erythropoietin Drugs Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Erythropoietin Drugs Sales by Region (2024-2034) & (K Pcs)
Table 90. Asia-Pacific Erythropoietin Drugs Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific Erythropoietin Drugs Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific Erythropoietin Drugs Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America Erythropoietin Drugs Sales by Country (2018-2024) & (K Pcs)
Table 94. Latin America Erythropoietin Drugs Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Erythropoietin Drugs Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Erythropoietin Drugs Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Erythropoietin Drugs Sales by Country (2024-2034) & (K Pcs)
Table 98. Latin America Erythropoietin Drugs Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America Erythropoietin Drugs Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America Erythropoietin Drugs Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa Erythropoietin Drugs Sales by Country (2018-2024) & (K Pcs)
Table 102. Middle East and Africa Erythropoietin Drugs Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Erythropoietin Drugs Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Erythropoietin Drugs Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Erythropoietin Drugs Sales by Country (2024-2034) & (K Pcs)
Table 106. Middle East and Africa Erythropoietin Drugs Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa Erythropoietin Drugs Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa Erythropoietin Drugs Sales Market Share in Value by Country (2024-2034)
Table 109. Amgen Company Information
Table 110. Amgen Introduction and Business Overview
Table 111. Amgen Erythropoietin Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 112. Amgen Erythropoietin Drugs Product
Table 113. Amgen Recent Development
Table 114. Johnson & Johnson Company Information
Table 115. Johnson & Johnson Introduction and Business Overview
Table 116. Johnson & Johnson Erythropoietin Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 117. Johnson & Johnson Erythropoietin Drugs Product
Table 118. Johnson & Johnson Recent Development
Table 119. Roche Company Information
Table 120. Roche Introduction and Business Overview
Table 121. Roche Erythropoietin Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 122. Roche Erythropoietin Drugs Product
Table 123. Roche Recent Development
Table 124. Galenica Company Information
Table 125. Galenica Introduction and Business Overview
Table 126. Galenica Erythropoietin Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 127. Galenica Erythropoietin Drugs Product
Table 128. Galenica Recent Development
Table 129. Emcure Company Information
Table 130. Emcure Introduction and Business Overview
Table 131. Emcure Erythropoietin Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 132. Emcure Erythropoietin Drugs Product
Table 133. Emcure Recent Development
Table 134. Kyowa Hakko Kirin Company Information
Table 135. Kyowa Hakko Kirin Introduction and Business Overview
Table 136. Kyowa Hakko Kirin Erythropoietin Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 137. Kyowa Hakko Kirin Erythropoietin Drugs Product
Table 138. Kyowa Hakko Kirin Recent Development
Table 139. 3SBio Company Information
Table 140. 3SBio Introduction and Business Overview
Table 141. 3SBio Erythropoietin Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 142. 3SBio Erythropoietin Drugs Product
Table 143. 3SBio Recent Development
Table 144. Biocon Company Information
Table 145. Biocon Introduction and Business Overview
Table 146. Biocon Erythropoietin Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 147. Biocon Erythropoietin Drugs Product
Table 148. Biocon Recent Development
Table 149. LG Life Sciences Company Information
Table 150. LG Life Sciences Introduction and Business Overview
Table 151. LG Life Sciences Erythropoietin Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 152. LG Life Sciences Erythropoietin Drugs Product
Table 153. LG Life Sciences Recent Development
Table 154. Key Raw Materials Lists
Table 155. Raw Materials Key Suppliers Lists
Table 156. Erythropoietin Drugs Market Trends
Table 157. Erythropoietin Drugs Market Drivers
Table 158. Erythropoietin Drugs Market Challenges
Table 159. Erythropoietin Drugs Market Restraints
Table 160. Erythropoietin Drugs Distributors List
Table 161. Erythropoietin Drugs Downstream Customers
Table 162. Research Programs/Design for This Report
Table 163. Key Data Information from Secondary Sources
Table 164. Key Data Information from Primary Sources
List of Figures
Figure 1. Erythropoietin Drugs Product Picture
Figure 2. Global Erythropoietin Drugs Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Erythropoietin Drugs Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Erythropoietin Drugs Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of Epoetin-alfa
Figure 6. Global Epoetin-alfa Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of Darbepoetin-alfa
Figure 8. Global Darbepoetin-alfa Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Product Picture of Epoetin-beta
Figure 10. Global Epoetin-beta Sales YoY Growth (2018-2034) & (K Pcs)
Figure 11. Product Picture of Others
Figure 12. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 13. Global Erythropoietin Drugs Sales by Type (2018-2034) & (US$ Million)
Figure 14. Global Erythropoietin Drugs Sales Market Share by Type in 2022 & 2034
Figure 15. North America Erythropoietin Drugs Sales Market Share in Volume by Type in 2022
Figure 16. North America Erythropoietin Drugs Sales Market Share in Value by Type in 2022
Figure 17. Europe Erythropoietin Drugs Sales Market Share in Volume by Type in 2022
Figure 18. Europe Erythropoietin Drugs Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Erythropoietin Drugs Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Erythropoietin Drugs Sales Market Share in Value by Type in 2022
Figure 21. Latin America Erythropoietin Drugs Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Erythropoietin Drugs Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Erythropoietin Drugs Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Erythropoietin Drugs Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Erythropoietin Drugs Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Erythropoietin Drugs Revenue in 2022
Figure 27. Erythropoietin Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Anemia
Figure 29. Global Anemia Sales YoY Growth (2018-2034) & (K Pcs)
Figure 30. Product Picture of Kidney Disorders
Figure 31. Global Kidney Disorders Sales YoY Growth (2018-2034) & (K Pcs)
Figure 32. Product Picture of Other
Figure 33. Global Other Sales YoY Growth (2018-2034) & (K Pcs)
Figure 34. Global Erythropoietin Drugs Sales by Application (2018-2034) & (US$ Million)
Figure 35. Global Erythropoietin Drugs Sales Market Share by Application in 2022 & 2034
Figure 36. North America Erythropoietin Drugs Sales Market Share in Volume by Application in 2022
Figure 37. North America Erythropoietin Drugs Sales Market Share in Value by Application in 2022
Figure 38. Europe Erythropoietin Drugs Sales Market Share in Volume by Application in 2022
Figure 39. Europe Erythropoietin Drugs Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Erythropoietin Drugs Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Erythropoietin Drugs Sales Market Share in Value by Application in 2022
Figure 42. Latin America Erythropoietin Drugs Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Erythropoietin Drugs Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Erythropoietin Drugs Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Erythropoietin Drugs Manufacturing Cost Structure
Figure 47. Erythropoietin Drugs Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed